Skip to main content
SpringerLink
Log in

Catch-22 for regulators: risk aversion may be harmful

  • Incidence study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Eichler H-G, et al. The risks of risk aversion in drug regulation. Nature Reviews Drug Discovery : [10 pages], 15 Nov 2013. Available from: URL: http://dx.doi.org/10.1038/nrd4129

  2. EMA. Mitigating risk aversion in medicines regulation in the interest of public health. Internet Document : 15 Nov 2013. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Catch-22 for regulators: risk aversion may be harmful. Reactions Weekly 1481, 2 (2013). https://doi.org/10.1007/s40278-013-7551-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-7551-3

Search

Navigation